Major systemic infection following breast cancer surgery and oncological outcomes
British Journal of Surgery · 29.11.2025 · 112 (12)
DOI: 10.1093/bjs/znaf233 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 02.12.2025. Verfasst von Linda Adwall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Breast Surgery, Södersjukhuset, Stockholm, Sweden. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Neoplasm Recurrence, Local, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Percy Falk foundation, Karolinska Institutet.
Abstract (Originalsprache)
Background
Postoperative infections are well-known complications following cancer surgery and are associated with worse oncological outcomes in several cancer types. The influence of major systemic postoperative infections on the risk of breast cancer recurrence remains unexplored. The primary aim of this study was to assess the risk of distant recurrence following major systemic infection. Secondary aims were to assess this risk after other major events such as stroke, myocardial infarction and pulmonary embolism.
Methods
This nationwide cohort study included patients who underwent breast cancer surgery in Sweden between 2008 and 2019. The study cohort was identified using BCBaSe 3.0, a database linking the Swedish National Breast Cancer Quality Register with other national population-based healthcare registers. The primary exposure was major systemic infection within 90 days of surgery, with a secondary analysis of other major events. The primary outcome was distant recurrence, whereas secondary outcomes included locoregional recurrence, overall survival, and breast cancer-specific survival.
Results
Among 82 102 patients included, 1.8% (n = 1461) experienced a major systemic infection, and 0.6% (n = 516) other major events within 90 days of surgery. In adjusted analyses, major systemic infection was associated with increased risk of distant recurrence (HR 1.23, 95% c.i. 1.07–1.41), overall death (HR 1.47, 1.32–1.64), breast cancer-specific death (HR 1.27, 1.06–1.51), but not with locoregional recurrence.
Conclusions
At a median follow-up of 4.8 years, major systemic postoperative infections were associated with an increased risk of distant recurrence, overall death, and breast cancer-specific death, highlighting the importance of timely and effective treatment of postoperative infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Division of Breast Surgery, Södersjukhuset, Stockholm, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Breast, Endocrine Tumors and Sarcoma, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
- Department of Surgical Sciences, Section of Plastic Surgery, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
ORCID-Profile: Linda Adwall, Irma Fredriksson, Helena Sackey
Förderung
- Percy Falk foundation
- Karolinska Institutet
Zitieren
APA
Adwall, L., Fredriksson, I., Hultin, H., Stålberg, P., Mani, M., Norlén, O., & Sackey, H. (2025). Major systemic infection following breast cancer surgery and oncological outcomes. British Journal of Surgery, 112(12). https://doi.org/10.1093/bjs/znaf233
Vancouver
Adwall L, Fredriksson I, Hultin H, Stålberg P, Mani M, Norlén O, et al. Major systemic infection following breast cancer surgery and oncological outcomes. British Journal of Surgery. 2025;112(12). doi:10.1093/bjs/znaf233
BibTeX
@article{Adwall2025,
author = {Adwall, Linda and Fredriksson, Irma and Hultin, Hella and Stålberg, Peter and Mani, Maria and Norlén, Olov and Sackey, Helena},
title = {Major systemic infection following breast cancer surgery and oncological outcomes},
journal = {British Journal of Surgery},
year = {2025},
volume = {112},
number = {12},
doi = {10.1093/bjs/znaf233}
}
EUVIMED